
Influenza vaccine
1945 · vaccine that is updated each season to match the flu virus
Influenza, or flu, is an acute respiratory infection caused by type A and type B viruses. Its main difficulty is how quickly the surface antigens of the virus change; these are the proteins the immune system recognises. A person who has had the flu is not fully protected against the variants circulating the following year, which is why epidemics recur every winter. Before vaccines existed, control depended almost entirely on general measures and on treating complications, with no specific preventive tool.
The first steps towards a vaccine came in the 1930s, when researchers began growing the virus in the laboratory. A decisive milestone was the 1931 report by Ernest William Goodpasture and colleagues at Vanderbilt University, which showed that viruses could multiply in embryonated hens' eggs. This technique made it possible to produce virus in useful quantities. Following work by researchers including Thomas Francis Jr., Jonas Salk, Wilson Smith and Macfarlane Burnet, the first experimental influenza vaccines were developed. Francis also played a prominent role in field trials and in assessing the immune response.
In the 1940s the US military developed the first approved inactivated vaccines, made with killed virus, which were used during the Second World War. Manufacturers later improved purity by removing egg proteins and reducing systemic reactions after injection. Large-scale vaccination in the United States began in 1945.
Resistance was not only technical. During the 1976 swine flu scare, the vaccination programme was rushed and suffered delays and public relations problems. It was cancelled after about 24 per cent of the population had been vaccinated. An excess of deaths and hospitalisations from Guillain-Barré syndrome, a rare neurological complication, was estimated, showing that the vaccine was not free of risk. Decades later, vaccination during the 2009 pandemic renewed debate about the safety of some vaccines.
Today the vaccine is reviewed every year, following recommendations from the World Health Organization, which rely on surveillance of circulating viruses. Its effectiveness varies from season to season, but it usually offers moderate to high protection. The WHO and the US Centers for Disease Control and Prevention recommend annual vaccination especially for older adults, pregnant women, people with chronic conditions and health workers. Its value lies mainly in reducing severe cases and complications rather than preventing every infection.
Key dates
- 1931 Goodpasture and colleagues describe growing the virus in embryonated hens' eggs.
- 1940 The US military develops the first approved inactivated influenza vaccines.
- 1945 Large-scale availability of the vaccine begins in the United States.
- 1976 The swine flu vaccination programme is cancelled after about 24 per cent of the population is vaccinated.
- 2012 The FDA approves vaccines grown in cell cultures.
Key figures: Thomas Francis Jr.
Sources
Original Medicapedia text based on:
Last updated: 5 November 2026 · How Medicapedia is made
A project by Alejandro Rosàs Navarro, family physician and specialist in preventive medicine and public health. Spotted a mistake? Write to info@medicapedia.org.